Did DJT Try to Get an Exclusive on German Coroa Scientists
Mar 17, 2020 3:21:14 GMT
sgard434 likes this
Post by miamianne67 on Mar 17, 2020 3:21:14 GMT
WHO KNOWS? The German govt is in an uproar but Curevac denies it.
Trump reportedly tried to poach German scientists working on a coronavirus vaccine and offered cash so it would be exclusive to the US
Thomas Colson and Andrew Dunn Mar 15, 2020, 12:26 PM
Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS/Andreas Gebert
An employee of the German biopharmaceutical company CureVac demonstrating research workflow on a vaccine for COVID-19 at a laboratory in Tuebingen, Germany, on Thursday. REUTERS/Andreas Gebert
President Donald Trump reportedly tried to poach German scientists working on a coronavirus vaccine so he could secure exclusive rights to it for the US.
The newspaper Welt am Sonntag reported that the Trump administration had offered large sums of cash to Germany-based biotech company CureVac to secure rights for the vaccine work, "but only for the USA."
The German government is battling back, offering financial incentives to the company to remain in Germany.
Karl Lauterbach, a senior German politician and professor of epidemiology, said in response to the report: "The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits."
CureVac tweeted Monday it "rejects all allegations from press" about any offers from the US government.
Trump reportedly tried to poach German scientists working on a coronavirus vaccine and offered cash so it would be exclusive to the US
Thomas Colson and Andrew Dunn Mar 15, 2020, 12:26 PM
Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS/Andreas Gebert
An employee of the German biopharmaceutical company CureVac demonstrating research workflow on a vaccine for COVID-19 at a laboratory in Tuebingen, Germany, on Thursday. REUTERS/Andreas Gebert
President Donald Trump reportedly tried to poach German scientists working on a coronavirus vaccine so he could secure exclusive rights to it for the US.
The newspaper Welt am Sonntag reported that the Trump administration had offered large sums of cash to Germany-based biotech company CureVac to secure rights for the vaccine work, "but only for the USA."
The German government is battling back, offering financial incentives to the company to remain in Germany.
Karl Lauterbach, a senior German politician and professor of epidemiology, said in response to the report: "The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits."
CureVac tweeted Monday it "rejects all allegations from press" about any offers from the US government.
